Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu-Sheng Zeng

Showing results (121-130 of 267) with videos related to

Pageof 27
Sort By:
Medicine|February 5, 2016
Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy EraWen-Hui Chen, Lin-Quan Tang, Shan-Shan Guo, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 12, 2015
Decreased Expression of FADS1 Predicts a Poor Prognosis in Patients with Esophageal Squamous Cell CarcinomaYong Du, Shu-Mei Yan, Wan-Yi Gu, et al.
Nature Communications|May 13, 2022
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variantsYin-Feng Kang, Cong Sun, Jing Sun, et al.
Plos One|July 21, 2012
Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patientsTian-Run Liu, Li-Hua Xu, An-Kui Yang, et al.
Science China. Life Sciences|March 17, 2026
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virusQingtai Liang, Qian-Ying Zhu, Xin-Yan Fang, et al.
Journal of Cancer|August 19, 2017
Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome SequencingShan Xing, Xin Zheng, Li-Qiang Wei, et al.
Scientific Reports|November 14, 2015
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapyXiao-Jing Du, Ling-Long Tang, Lei Chen, et al.
Signal Transduction and Targeted Therapy|February 9, 2022
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variantsCong Sun, Yin-Feng Kang, Yuan-Tao Liu, et al.
Cell Death and Differentiation|July 4, 2025
The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinomaTing Yang, Zhi-Rui Lin, Tian-Liang Xia, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinomaYa-Xian Wu, Shan Xing, Yu Wang, et al.
Pageof 27

Showing results (121-130 of 267) with videos related to

Sort By:
Pageof 27
Medicine|February 5, 2016
Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy EraWen-Hui Chen, Lin-Quan Tang, Shan-Shan Guo, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 12, 2015
Decreased Expression of FADS1 Predicts a Poor Prognosis in Patients with Esophageal Squamous Cell CarcinomaYong Du, Shu-Mei Yan, Wan-Yi Gu, et al.
Nature Communications|May 13, 2022
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variantsYin-Feng Kang, Cong Sun, Jing Sun, et al.
Plos One|July 21, 2012
Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patientsTian-Run Liu, Li-Hua Xu, An-Kui Yang, et al.
Science China. Life Sciences|March 17, 2026
A potent human neutralizing antibody targeting the receptor-binding site in the glycoprotein gp350 of Epstein-Barr virusQingtai Liang, Qian-Ying Zhu, Xin-Yan Fang, et al.
Journal of Cancer|August 19, 2017
Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome SequencingShan Xing, Xin Zheng, Li-Qiang Wei, et al.
Scientific Reports|November 14, 2015
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapyXiao-Jing Du, Ling-Long Tang, Lei Chen, et al.
Signal Transduction and Targeted Therapy|February 9, 2022
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variantsCong Sun, Yin-Feng Kang, Yuan-Tao Liu, et al.
Cell Death and Differentiation|July 4, 2025
The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinomaTing Yang, Zhi-Rui Lin, Tian-Liang Xia, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinomaYa-Xian Wu, Shan Xing, Yu Wang, et al.
Pageof 27